About Us

Superior equipment to diagnose Pulmonary Embolism

Cyclomedica Canada Limited was incorporated in 2003 and is the wholly owned subsidiary of Cyclopharm Limited, an Australian public company that operates in the Nuclear Medicine industry. Cyclopharm is the developer and manufacturer of the Technegas Generator System.

Our Product

Cyclomedica Canada is the exclusive provider of Technegas Generator Systems to the Canadian market. The Technegas Generator produces Technegas, which is used in the diagnosis of Pulmonary Embolism (PE.)

For years, patients presenting with the possible diagnosis of Pulmonary Embolism (PE) underwent a Nuclear Medicine Ventilation/Perfusion exam. The results were often sub-optimal due to the limitations of the imaging agents available. Because PE is a very common and potentially fatal condition that affects a as many as 600,000 patients annually in the US alone, with a mortality rate of up to 15%, the limitations of the current imaging agents motivated Cyclomedica to develop a superior agent for the Nuclear Medicine Ventilation/Perfusion exam.

In 1986, Cyclomedica Australia PTY Limited released Technegas as a new imaging agent which has since been recognized as the agent of choice for Ventilation/Perfusion exams in the diagnosis of Pulmonary Embolism.

Cyclomedica Canada was up and running in late 2003 and on the strength of the product's reputation and long awaited arrival in Canada, Technegas was an immediate success. Many of our first installations included some of the top university medical centers in Canada.

Today, thanks to the inherent and proven benefits Technegas offers our healthcare community at large, Cyclomedica Canada’s sales of Technegas have quickly grown to represent more than 10% of the total Cyclomedica Canada Limited revenues world wide…and we have just begun.